Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27504,105,2.24 [1.38-3.64],0.001159132024426
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28081,144,1.54 [0.98-2.43],0.0593150311335958
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27825,1004,1.42 [1.19-1.69],9.05710872643344e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,28112,301,1.84 [1.35-2.49],9.861042313268986e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,27318,2757,1.37 [1.23-1.52],6.4424489888494415e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27570,2082,1.69 [1.50-1.91],8.006386136716305e-18
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27899,1004,1.52 [1.29-1.81],1.2785131312911225e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,28025,43,2.65 [1.34-5.23],0.0051399148978512
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26840,643,1.79 [1.44-2.22],1.670897038911395e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25947,617,2.30 [1.86-2.84],1.2811931813072292e-14
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,26200,170,2.19 [1.47-3.26],0.0001266055734848
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20939,1210,1.90 [1.62-2.21],4.865952898807781e-16
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25960,282,2.41 [1.79-3.25],9.275358932242277e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,28062,1167,1.50 [1.28-1.75],7.342732924433073e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Mycoses,28171,360,1.70 [1.28-2.26],0.0002294011103327
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27428,607,1.85 [1.49-2.29],1.7046470032297816e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,28109,710,1.68 [1.37-2.06],6.015718308887853e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27041,146,1.53 [0.98-2.41],0.0633247572715517
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,28213,33,1.80 [0.71-4.54],0.2126546222607556
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,28021,622,1.80 [1.45-2.23],1.0013061506911417e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28053,71,1.63 [0.86-3.07],0.133570044176799
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28117,168,2.03 [1.37-3.01],0.0004021653448025
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28101,152,1.86 [1.22-2.84],0.0039756824719342
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27157,336,1.61 [1.19-2.16],0.0018685171571378
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,27067,246,0.99 [0.69-1.43],0.9774704844617004
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26975,80,2.46 [1.42-4.25],0.0012810231012218
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,28184,51,1.05 [0.48-2.31],0.8942279316969208
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28151,129,1.37 [0.84-2.21],0.2064961494190784
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Viral warts,28068,46,1.77 [0.82-3.83],0.1461148337330254
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],28070,48,0.98 [0.44-2.21],0.9684107490316184
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm,27920,322,1.03 [0.75-1.40],0.8729150681985641
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28119,77,0.86 [0.45-1.65],0.6586370083622124
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28099,82,0.60 [0.32-1.13],0.1122645238959731
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12579,45,1.11 [0.48-2.59],0.8059484687582387
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",28015,1196,1.23 [1.04-1.44],0.014066162470418
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of meninges,28201,49,0.41 [0.18-0.92],0.0316064045576323
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28178,51,0.91 [0.41-2.01],0.8105445585196946
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,28191,94,0.93 [0.52-1.67],0.8204668425594384
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm of ovary,15570,98,0.85 [0.48-1.50],0.57001212964121
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,28207,276,1.23 [0.88-1.72],0.2270208017041851
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Caecum,28202,206,1.32 [0.90-1.95],0.1574805861286574
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28144,60,1.27 [0.62-2.60],0.5165657778729911
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,28205,177,1.32 [0.87-2.01],0.191986084095956
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Rectum,28168,300,1.41 [1.02-1.94],0.0365771985611167
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,28138,556,1.11 [0.88-1.41],0.3813971267813174
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,28206,316,1.29 [0.94-1.76],0.117525459010945
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Carcinoma in situ of breast,13380,89,1.07 [0.58-1.95],0.8353430690080937
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13429,102,1.09 [0.62-1.92],0.7558621653600719
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",24367,31,1.66 [0.61-4.54],0.3216198436135207
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",24376,40,3.08 [1.46-6.48],0.0030856803420339
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28169,114,1.27 [0.75-2.13],0.369350890821751
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Haemangioma, any site",28169,112,1.28 [0.76-2.15],0.3593928044270632
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Leiomyoma of uterus,14932,422,1.12 [0.86-1.46],0.4106482462559557
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Lung cancer and mesothelioma,20962,178,1.54 [1.01-2.35],0.0428752427965536
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Lymphoid leukaemia,24366,30,0.82 [0.29-2.35],0.716250765553315
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24485,149,1.85 [1.18-2.89],0.0070576054545809
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",24420,84,1.19 [0.64-2.21],0.5866841452261427
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13485,85,0.56 [0.30-1.05],0.0698839769431969
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",24388,52,1.66 [0.78-3.55],0.1894906136036018
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",24403,67,2.70 [1.53-4.76],0.0006011604484563
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",24408,72,0.96 [0.49-1.87],0.8937375246502675
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13455,55,1.19 [0.56-2.54],0.646012503638919
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",24394,58,0.81 [0.38-1.71],0.5797351334751275
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11354,418,0.91 [0.69-1.21],0.5142794157266539
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",24428,92,0.65 [0.36-1.18],0.1597090138386803
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",24393,57,1.56 [0.74-3.28],0.243468983270974
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,24399,63,0.84 [0.41-1.74],0.643484635448329
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Melanocytic naevi,27971,219,1.04 [0.71-1.53],0.8222337837576063
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Melanocytic naevi of trunk,28164,98,1.07 [0.60-1.90],0.8133859849119885
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Melanoma in situ,24350,50,0.66 [0.29-1.49],0.3196834612318533
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",24396,60,2.22 [1.13-4.34],0.0198474781945446
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24459,123,1.86 [1.14-3.02],0.0126354224997194
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",24458,122,1.17 [0.70-1.95],0.5488955864588072
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",24406,70,1.57 [0.82-3.02],0.1724640013165833
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,Other benign neoplasms of skin,28027,142,1.14 [0.71-1.82],0.5964464322101293
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24995,659,1.02 [0.82-1.28],0.8561398588478517
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",25027,691,1.06 [0.85-1.32],0.6056949239109488
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27939,292,1.64 [1.20-2.25],0.0021851055398637
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26770,59,4.31 [2.62-7.09],8.764456496623874e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27717,70,0.74 [0.38-1.47],0.393651870196378
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27397,2268,1.59 [1.41-1.78],3.265060261995693e-15
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,27004,25,3.27 [1.34-7.98],0.0091536801221855
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27853,34,2.24 [0.95-5.32],0.0668716983479408
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27757,1046,1.68 [1.42-1.98],1.6570766150559591e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27757,1046,1.68 [1.42-1.98],1.6570766150559591e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,26770,59,3.19 [1.79-5.68],8.790584978849727e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27923,944,1.69 [1.42-2.01],3.949502450772326e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27932,113,1.94 [1.20-3.16],0.0072463106442205
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27700,53,1.82 [0.89-3.73],0.1017493037659031
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27688,41,1.64 [0.71-3.80],0.2476573654280055
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,28013,194,2.25 [1.57-3.22],9.833104372470834e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,28133,70,3.23 [2.00-5.22],1.6970140523889636e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27983,164,2.76 [1.93-3.94],2.4209159607467452e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,27055,76,1.68 [0.91-3.08],0.0968595949934412
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,24251,216,2.76 [1.96-3.90],6.24420423708252e-09
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26257,126,0.74 [0.44-1.22],0.238526224974213
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26272,141,1.03 [0.64-1.66],0.9003571537711952
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,24073,38,1.51 [0.61-3.75],0.3746056141018451
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,26204,72,2.38 [1.33-4.24],0.0033081726599427
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25868,154,1.57 [1.01-2.42],0.0433296964731135
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",28064,174,1.22 [0.80-1.86],0.3665624346666867
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27938,48,0.82 [0.36-1.88],0.6426747759602189
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,27928,38,1.23 [0.49-3.09],0.6555562041577337
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27793,1661,1.41 [1.23-1.61],6.026858066417594e-07
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,25274,1611,1.36 [1.19-1.57],9.327797227845275e-06
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",24077,42,1.20 [0.50-2.87],0.6801406446923723
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",26504,58,1.83 [0.92-3.64],0.0833561845291949
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,24228,193,1.66 [1.12-2.47],0.0123023845273496
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,24101,66,1.71 [0.87-3.38],0.1223007439327423
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,26472,2437,1.07 [0.95-1.20],0.268269979491711
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,24157,122,1.29 [0.77-2.14],0.3296300787403661
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,24435,400,1.54 [1.17-2.04],0.0021336493573313
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28113,276,1.23 [0.88-1.72],0.2208238037343907
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27949,112,1.72 [1.04-2.82],0.0331277292471603
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,24135,100,1.29 [0.73-2.27],0.3784657911567893
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",24074,39,4.42 [2.32-8.42],5.896669596534055e-06
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27780,1334,1.35 [1.16-1.57],8.213215452137148e-05
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,24165,130,3.70 [2.59-5.29],6.057961077437559e-13
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,24204,169,3.40 [2.35-4.92],8.309550728446324e-11
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24425,390,1.50 [1.13-1.99],0.0054756812327454
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,24097,62,3.09 [1.63-5.87],0.0005383895541773
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27942,105,1.61 [0.96-2.72],0.0716890657843254
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,24340,305,1.97 [1.45-2.68],1.394440770060942e-05
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,24335,300,1.27 [0.92-1.76],0.1431456513508716
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25775,61,1.69 [0.85-3.37],0.1368202688550698
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27516,3481,1.16 [1.05-1.28],0.0024386023311847
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,26483,37,1.09 [0.44-2.72],0.852646393265955
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,26508,62,0.87 [0.42-1.78],0.7008683249098874
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,28025,1949,1.15 [1.01-1.31],0.0291715460008234
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",28029,1946,1.14 [1.01-1.30],0.0412516392604593
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,26484,38,2.14 [0.96-4.75],0.0625359246846145
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27885,1263,1.14 [0.97-1.33],0.1089227231419254
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24948,913,1.78 [1.48-2.13],4.552516280022975e-10
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,28203,140,3.32 [2.37-4.65],2.7853998478297375e-12
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,27925,35,1.23 [0.48-3.16],0.6676772952638261
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26711,89,1.57 [0.90-2.75],0.1134229785416751
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26740,118,1.24 [0.74-2.06],0.4155226645138012
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",24167,132,2.17 [1.39-3.41],0.0007023761408897
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26388,122,2.98 [2.06-4.32],7.015413764771543e-09
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1737,71,3.71 [2.01-6.83],2.619035864197801e-05
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1846,195,2.52 [1.73-3.66],1.4778045420511674e-06
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,26305,39,3.66 [1.98-6.79],3.637183166567653e-05
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1704,38,6.88 [3.24-14.63],5.311989553292015e-07
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27786,1520,1.63 [1.42-1.87],1.931963013605417e-12
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27963,73,1.80 [0.96-3.38],0.0678366223275249
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25988,274,1.71 [1.25-2.34],0.0008301039836799
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24452,417,2.21 [1.71-2.86],1.3299912306728051e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28124,178,1.28 [0.84-1.93],0.2523537083209026
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27463,58,2.30 [1.16-4.55],0.0171298575351598
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Angina pectoris,26919,801,1.27 [1.04-1.55],0.0167831419270566
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27512,107,1.23 [0.72-2.12],0.4504674299132182
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27435,30,1.43 [0.52-3.95],0.4867781875424672
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27511,106,2.06 [1.24-3.44],0.0055413740213658
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,20128,954,1.38 [1.15-1.65],0.0004902240789481
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,AV-block,25689,184,1.17 [0.77-1.79],0.4534876649067392
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28179,267,0.93 [0.66-1.32],0.6988436973365325
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,19292,118,2.89 [1.80-4.64],1.1844389394674232e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25639,134,2.12 [1.33-3.37],0.0015939426609589
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25586,81,2.28 [1.27-4.07],0.0054763490622653
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,28215,21,1.10 [0.32-3.73],0.8803098543630095
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Conduction disorders,26043,538,1.48 [1.16-1.88],0.0015985315959587
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27483,1375,1.38 [1.19-1.60],2.807314569663541e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,26239,6149,1.19 [1.11-1.28],1.32031727952933e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,27032,187,1.34 [0.89-2.01],0.1630105796632024
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Endocarditis,25548,43,0.76 [0.32-1.83],0.5425873592767179
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",28094,521,1.89 [1.50-2.38],5.703685092485024e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypertension,26824,5006,1.19 [1.10-1.29],1.2427364477783202e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",26841,5023,1.20 [1.11-1.30],4.11245018413039e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",28041,60,4.53 [3.01-6.81],4.013518546323216e-13
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21906,88,3.11 [2.00-4.81],3.9061456668399146e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21881,63,3.87 [2.59-5.78],4.1328607109509897e-11
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Hypotension,28111,707,1.57 [1.28-1.92],1.862859222902616e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27676,65,1.00 [0.50-2.01],0.9910606019278678
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27649,1531,1.34 [1.16-1.55],5.590356589415604e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27980,310,1.01 [0.73-1.39],0.9501280433980056
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,25700,195,1.70 [1.14-2.53],0.0088492151516453
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27955,610,1.49 [1.19-1.86],0.0004380885375456
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26614,496,1.53 [1.19-1.96],0.0008390656950586
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28158,122,1.08 [0.65-1.80],0.7639153994058065
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",28199,206,1.60 [1.09-2.34],0.0155980541772138
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,26886,41,3.11 [1.56-6.24],0.001345495597256
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other aneurysm,27456,51,0.93 [0.42-2.06],0.8619328986459203
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,25751,246,1.67 [1.18-2.38],0.0038160529930148
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27468,63,1.19 [0.59-2.40],0.6240518598906947
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27549,144,1.99 [1.29-3.08],0.0019947394412822
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,25635,130,1.47 [0.90-2.39],0.1254567058300944
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,26919,74,0.99 [0.51-1.90],0.9749723848681068
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26894,49,2.72 [1.39-5.32],0.0034223733338771
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,27427,38,1.23 [0.49-3.08],0.6594357593941371
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26938,93,1.03 [0.57-1.84],0.932393912545852
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,26097,592,1.76 [1.41-2.20],7.134786712245701e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,27450,46,3.95 [2.22-7.04],3.186110676595472e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27752,347,2.30 [1.76-3.02],1.1978711448148199e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27762,160,2.81 [1.97-4.01],1.3602482559761457e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27626,237,1.70 [1.19-2.41],0.0031399379514553
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19427,253,2.00 [1.45-2.77],2.8548047274373782e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27587,207,2.22 [1.56-3.17],1.0755785571354e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27104,259,1.24 [0.88-1.76],0.2202881170836232
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27946,344,0.95 [0.70-1.30],0.7650731987784155
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28174,336,1.37 [1.02-1.85],0.0393780924034387
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,25684,179,1.90 [1.26-2.87],0.0022279146791201
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27758,156,2.79 [1.94-4.00],2.704031417348085e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,27507,118,1.83 [1.12-2.99],0.0150170536792784
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27973,362,1.02 [0.76-1.37],0.9000267544494466
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27947,398,1.10 [0.83-1.46],0.5009300678330211
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27652,55,1.39 [0.66-2.95],0.3882862252123038
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27461,57,0.49 [0.23-1.05],0.066861025170973
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27817,147,0.95 [0.60-1.52],0.8461457988938315
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27531,186,1.36 [0.90-2.03],0.1407817452564693
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Varicose veins,27168,323,1.12 [0.82-1.52],0.490667566857794
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,27414,48,1.39 [0.63-3.09],0.4149326191480985
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,28038,540,1.00 [0.79-1.28],0.9719562248824828
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28055,383,0.97 [0.73-1.29],0.8299714480062989
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",25170,1450,1.21 [1.04-1.40],0.0115298469690071
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,Any mental disorder,27451,3731,1.17 [1.07-1.28],0.0008248248766867
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27990,453,0.92 [0.70-1.20],0.5250426786525636
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25412,1692,1.41 [1.23-1.61],5.114010557659305e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23814,94,1.72 [0.99-2.99],0.0548183444199548
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,Smoking dependency,27665,1541,1.19 [1.03-1.37],0.0185069300664394
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",25512,1792,1.08 [0.95-1.24],0.2511636855122054
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter V Mental and behavioural disorders,Vascular dementia,28096,21,1.07 [0.32-3.62],0.9106362204537208
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Alzheimer disease,28215,66,0.81 [0.40-1.64],0.5582027395997466
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Bell's palsy,26522,75,1.30 [0.69-2.46],0.4150348650459482
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26937,490,1.39 [1.09-1.77],0.0089599422540853
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Cerebral cysts,27860,209,1.61 [1.11-2.33],0.0119958711335636
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28132,235,1.31 [0.92-1.89],0.1371756817915279
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,28070,24,1.69 [0.56-5.14],0.3522689002383323
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,28200,52,0.69 [0.32-1.52],0.358877492929457
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27712,61,0.57 [0.27-1.18],0.1280325847013185
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Epilepsy,26621,262,1.70 [1.22-2.36],0.0016505441389788
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27725,1366,1.29 [1.11-1.50],0.000721168311866
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,28185,272,1.23 [0.87-1.72],0.2421313298164389
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27688,1678,1.30 [1.13-1.48],0.0001874227443649
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,27838,54,2.97 [1.56-5.65],0.0008984813604257
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Hemiplegia,28064,167,1.41 [0.92-2.16],0.1102082268652896
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Hydrocephalus,27697,46,1.21 [0.53-2.77],0.6486726347749306
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,28191,62,1.37 [0.68-2.75],0.3799459157782371
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26526,79,1.37 [0.74-2.55],0.3162527332358903
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26531,84,2.15 [1.24-3.74],0.0067662771225434
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Memory loss,28061,75,1.17 [0.62-2.24],0.6267027395868068
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Migraine,26787,428,1.27 [0.98-1.66],0.0757046292754368
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28126,381,1.26 [0.95-1.67],0.1152517307124727
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Motor neuron disease,20562,99,1.65 [0.94-2.89],0.0801003223506619
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28016,145,1.35 [0.85-2.13],0.2046579716908889
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27596,1149,1.33 [1.13-1.56],0.0005779610749977
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Neurological diseases,26761,3129,1.24 [1.12-1.37],2.032189969800495e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,28122,76,1.84 [1.01-3.37],0.046895711717136
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26840,393,1.21 [0.91-1.60],0.1821151286760276
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",28142,239,2.14 [1.54-2.97],5.197705127871887e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23544,310,1.49 [1.09-2.04],0.0127764945391038
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27711,60,1.61 [0.79-3.28],0.1904139606967318
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27764,113,1.45 [0.86-2.43],0.1594901198312583
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,28001,88,1.88 [1.08-3.28],0.0268063799614325
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26539,92,1.52 [0.86-2.67],0.1459815400763333
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other headache syndromes,26421,62,1.42 [0.71-2.84],0.3268128492651552
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other neurological diseases,28090,439,1.42 [1.09-1.84],0.0085831757955173
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Other sleep disorders,26952,593,1.35 [1.08-1.69],0.0086053835790553
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Parkinson's disease,28202,162,0.98 [0.63-1.54],0.9464165004339156
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27716,65,1.17 [0.59-2.32],0.64869081904872
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,28214,46,2.45 [1.23-4.87],0.0107168036162552
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Sleep apnoea,27965,516,1.28 [1.00-1.62],0.047331832997469
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27940,37,2.01 [0.85-4.76],0.110829484843237
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,28200,126,1.57 [0.97-2.56],0.0665072906061828
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,26480,33,2.19 [0.90-5.36],0.0855256746436657
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,28215,67,0.83 [0.42-1.67],0.6101147046030448
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),28083,20,1.15 [0.33-4.00],0.821526016684634
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27725,43,1.03 [0.44-2.45],0.9389228604377294
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27857,226,0.84 [0.58-1.23],0.3801251031476168
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28123,197,3.47 [2.63-4.58],1.7574040783511114e-18
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,27452,38,0.80 [0.32-2.00],0.6268331312264472
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27490,76,1.22 [0.65-2.31],0.5391200171135438
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",28121,30,1.41 [0.53-3.78],0.4951160473081031
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,28011,65,0.74 [0.36-1.50],0.3998289801188684
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1710,44,7.89 [4.01-15.51],2.093504959977361e-09
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2020,87,3.55 [2.03-6.19],8.080178625885576e-06
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27760,78,1.52 [0.82-2.80],0.18432184619392
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,28081,630,1.60 [1.29-1.99],2.000227237793015e-05
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27903,489,1.11 [0.86-1.43],0.418758251263876
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27552,138,1.64 [1.04-2.61],0.0342187889651582
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",28122,491,1.01 [0.78-1.31],0.9307673764460312
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,28202,52,1.22 [0.56-2.64],0.6213303656072242
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,28048,417,0.93 [0.70-1.23],0.6046508449264708
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",28172,226,1.05 [0.72-1.53],0.8011022681008905
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,28150,131,1.53 [0.95-2.48],0.0814913281894445
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,27431,17,0.91 [0.23-3.62],0.8903987689715016
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,27443,29,1.12 [0.39-3.24],0.8275248475512034
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,27447,33,1.43 [0.54-3.76],0.467717353586944
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,28164,392,1.26 [0.95-1.68],0.1054480111716164
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27876,104,1.51 [0.88-2.59],0.1361949779239234
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27658,27,1.40 [0.48-4.11],0.5403572707544095
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,28022,76,1.53 [0.81-2.89],0.1858502703607165
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,28097,151,0.85 [0.54-1.35],0.4947404031936683
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27796,165,0.76 [0.49-1.18],0.2240622838755653
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,28096,77,1.46 [0.77-2.74],0.243772112685871
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,28029,257,1.10 [0.78-1.57],0.5847801958696717
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27803,121,1.41 [0.86-2.33],0.1744390594616243
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27482,1084,1.20 [1.01-1.42],0.0411048733639721
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,28071,125,0.74 [0.44-1.23],0.2429324550631054
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,28190,114,1.63 [0.99-2.70],0.0559265999549141
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27685,271,1.00 [0.71-1.42],0.9833023813266027
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27984,38,1.15 [0.46-2.89],0.7651084325502233
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,28187,37,1.40 [0.56-3.49],0.4702015268865692
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,27454,40,2.12 [0.94-4.78],0.0692720664449627
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27533,119,0.76 [0.45-1.29],0.3102175534773494
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,27523,72,1.79 [0.95-3.40],0.0728663629355119
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27690,59,2.10 [1.09-4.04],0.027402539995566
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",27503,52,0.61 [0.27-1.34],0.2190007410062474
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27831,59,1.13 [0.54-2.37],0.7399411558627198
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27866,94,0.85 [0.47-1.54],0.5969455678767569
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27508,94,1.53 [0.87-2.69],0.1439587731314492
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,27578,127,1.06 [0.64-1.76],0.816640420969171
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,27487,36,1.01 [0.39-2.58],0.99049120963292
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,27254,856,1.10 [0.91-1.33],0.3407691689145766
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,27464,50,0.75 [0.34-1.68],0.4823966327856033
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27996,314,1.19 [0.87-1.63],0.2820844675541389
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27720,38,0.70 [0.28-1.77],0.4508888728337769
PDCD1LG2,Programmed cell death 1 ligand 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27812,130,2.07 [1.33-3.23],0.0012545880579152
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,28017,61,1.52 [0.75-3.05],0.2428526366244587
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,28172,98,0.94 [0.53-1.67],0.8441387282626571
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,28090,138,1.15 [0.72-1.85],0.552130252583838
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,28010,54,3.84 [2.31-6.39],2.198248611977989e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,28009,53,1.05 [0.49-2.28],0.8959252836983955
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,28124,539,1.23 [0.96-1.56],0.095684556051242
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27917,332,1.31 [0.96-1.77],0.0849651921338058
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27683,98,1.69 [0.98-2.91],0.0604224471234067
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27667,82,1.14 [0.61-2.12],0.6786419952622567
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,27919,84,1.81 [1.02-3.21],0.0422696683538921
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28076,241,1.81 [1.29-2.53],0.000556940582659
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27899,64,2.02 [1.07-3.83],0.0304442871326396
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,All influenza,26875,73,2.62 [1.45-4.74],0.0014883448466027
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26873,71,2.50 [1.36-4.60],0.0033199752064775
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),20908,124,0.76 [0.45-1.27],0.2877734048456242
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,28059,316,1.29 [0.94-1.76],0.1098904638213831
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",22439,1797,1.20 [1.05-1.37],0.008628381783124
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22552,1768,1.19 [1.04-1.36],0.0103578998642517
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27920,96,2.22 [1.33-3.71],0.0023474527873217
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26860,58,2.62 [1.37-5.03],0.0037642926124319
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Bronchiectasis,25112,187,1.44 [0.96-2.15],0.0769631613229227
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",24967,42,1.29 [0.55-3.02],0.5511582445670723
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,27332,2407,1.15 [1.03-1.29],0.0158526405157221
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26710,69,1.31 [0.67-2.55],0.4268411926809263
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26811,170,1.18 [0.77-1.80],0.4587828766506588
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",28111,732,1.16 [0.95-1.43],0.1489409061476184
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26770,129,0.89 [0.54-1.47],0.6499001263370033
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,26253,4345,1.30 [1.20-1.42],9.906991748551822e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27023,382,1.17 [0.88-1.56],0.2695332154728234
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Early onset COPD,27894,515,1.28 [1.00-1.63],0.0483957720187641
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Emphysema,25114,189,1.26 [0.85-1.86],0.2563495592936134
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26948,117,1.35 [0.81-2.25],0.2526362023298966
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,28024,1222,1.77 [1.52-2.07],2.2029258524307682e-13
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,26974,143,1.42 [0.90-2.26],0.1339360065651241
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Later onset COPD,26746,217,0.93 [0.64-1.35],0.6889086727094872
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,28206,160,2.14 [1.43-3.21],0.000235675996009
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Nasal polyp,26758,117,1.75 [1.07-2.87],0.025583293644711
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,28003,630,1.48 [1.19-1.84],0.00037294282436
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,28036,1265,1.59 [1.37-1.86],1.919075374348037e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27546,905,1.22 [1.01-1.46],0.0374143290309095
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other pleural conditions,26804,33,1.90 [0.75-4.85],0.1779815208864807
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28159,205,1.43 [0.98-2.10],0.0659132471287935
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,28132,860,1.55 [1.29-1.87],2.8803922751671425e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pleural effusion,27373,602,1.67 [1.34-2.08],5.508947030984589e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pleural plaque,26827,56,1.72 [0.83-3.54],0.1421747334774996
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27812,1010,1.88 [1.59-2.22],1.323606971229978e-13
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,28186,140,2.33 [1.53-3.56],8.9840572632924e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pneumothorax,26834,63,0.96 [0.47-1.95],0.9016361828400888
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pollen allergy,28180,271,1.22 [0.87-1.72],0.2435944539859938
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,27992,38,3.47 [1.78-6.76],0.0002553773188957
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,20822,38,1.49 [0.61-3.63],0.3846247789778466
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27983,610,1.55 [1.25-1.93],8.88323777295593e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26957,316,1.29 [0.95-1.77],0.1053036827750336
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Viral pneumonia,26994,192,1.10 [0.73-1.65],0.6587027401107151
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27942,169,0.94 [0.61-1.45],0.7797838384176656
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16311,102,1.10 [0.62-1.94],0.7446724033071486
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21608,65,0.95 [0.47-1.91],0.8900156885986354
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute appendicitis,28011,161,1.10 [0.71-1.72],0.6671010121922089
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute gastritis,22571,73,1.69 [0.90-3.19],0.1057143355294447
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,26590,163,1.34 [0.87-2.08],0.1869341902832067
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Acute peritonitis,27768,74,3.92 [2.41-6.37],3.536305719740963e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27424,86,2.56 [1.50-4.37],0.0005633296526643
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,22852,354,1.34 [1.00-1.81],0.0519634644135404
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",26483,56,1.82 [0.88-3.77],0.1067107371024053
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27796,56,1.79 [0.88-3.65],0.1099462348279112
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Cholecystitis,26611,184,0.77 [0.51-1.18],0.2307273013308199
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Cholelithiasis,27347,920,1.35 [1.13-1.62],0.001087616778385
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Chronic gastritis,22754,256,1.31 [0.93-1.86],0.1277642025518996
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,26471,44,4.47 [2.37-8.46],4.067412517435764e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",28063,82,3.81 [2.41-6.03],9.821018467720913e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Coeliac disease,26767,120,2.71 [1.78-4.11],3.014425515919362e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Collagenous colitis,26612,58,0.96 [0.45-2.02],0.912541138276957
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28028,211,0.82 [0.56-1.22],0.3288323278388807
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Constipation,27986,1193,1.31 [1.12-1.54],0.0008892436352322
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Crohn disease,26650,96,2.07 [1.23-3.50],0.006515910700314
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27859,68,2.42 [1.35-4.34],0.0030757935917031
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26648,94,2.24 [1.34-3.76],0.0021283735698823
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Dental caries,27362,270,0.99 [0.70-1.39],0.94895560464359
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26098,1851,1.15 [1.01-1.30],0.0405034249580651
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of appendix,28054,204,1.17 [0.79-1.73],0.4306135336488917
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of liver,28091,753,1.54 [1.26-1.87],2.540713002001589e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",26477,3979,1.11 [1.02-1.22],0.017278471010067
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27726,634,1.10 [0.88-1.37],0.405807236813817
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,28133,439,1.53 [1.18-1.99],0.0013652238430525
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27227,135,1.04 [0.64-1.68],0.8880587227010011
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,27060,70,1.79 [0.96-3.36],0.0682797015533902
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27934,1287,1.47 [1.26-1.71],7.046951095005204e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diseases of tongue,27073,123,1.44 [0.87-2.36],0.1534636092561573
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27686,1259,1.27 [1.09-1.49],0.0025666092006523
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,24032,2489,1.15 [1.02-1.28],0.0184011022551667
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,22644,146,1.67 [1.06-2.62],0.0265312539053479
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28142,115,1.55 [0.93-2.58],0.0936327969171669
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28079,84,0.60 [0.32-1.11],0.1054561730197899
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27441,103,3.23 [2.08-5.04],2.0099977818214213e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21728,185,0.81 [0.53-1.22],0.3121004889625856
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,23016,518,0.83 [0.65-1.07],0.14771423398674
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastric ulcer,22784,286,1.06 [0.76-1.47],0.7350490808876189
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,24782,2284,1.04 [0.93-1.17],0.4835014861422163
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22911,413,1.32 [1.01-1.73],0.0458410610773224
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,23047,8232,1.14 [1.07-1.21],3.573278209244215e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,GI-bleeding,27683,1036,1.38 [1.16-1.63],0.0002653672508641
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,27156,64,1.82 [0.95-3.48],0.0719997843166801
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22488,1312,1.10 [0.94-1.29],0.2175615613208566
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27393,55,2.58 [1.32-5.07],0.0057814675432646
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Hernia,27032,2785,1.14 [1.03-1.27],0.014129243857681
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Impacted teeth,28088,78,0.59 [0.31-1.13],0.1116294768584695
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Impaction of intestines,21577,34,3.48 [1.69-7.16],0.0007391045480317
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Inguinal hernia,24935,688,1.00 [0.80-1.24],0.9799628032190963
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",24327,80,0.77 [0.41-1.45],0.4175548422603105
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21618,75,0.47 [0.25-0.92],0.0266291876858084
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26787,140,2.59 [1.75-3.83],1.9552607970836607e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,22125,582,1.30 [1.03-1.63],0.0252352655498906
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,28189,396,1.47 [1.12-1.94],0.0051428529417346
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27272,718,1.41 [1.15-1.73],0.0010919849560398
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27457,903,1.30 [1.08-1.56],0.0058898028873391
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22649,151,1.32 [0.84-2.08],0.2290635616508493
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Oesophagitis,22997,499,1.22 [0.95-1.57],0.1183709025670565
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28171,136,0.88 [0.54-1.44],0.6153665913079895
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,24297,50,1.22 [0.56-2.68],0.6121298747666859
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22864,1321,1.26 [1.08-1.47],0.002894262187799
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26626,199,1.31 [0.88-1.95],0.1854336128410636
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,26592,165,1.36 [0.88-2.11],0.1690309178955224
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,23081,1538,1.06 [0.92-1.23],0.3939442011470268
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,26528,4985,1.19 [1.10-1.29],1.7527188707754392e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27066,201,1.20 [0.81-1.79],0.3579199831221421
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of liver,27947,609,1.46 [1.17-1.83],0.0008330564051174
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,23043,545,1.44 [1.13-1.82],0.0028514488221699
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,26513,86,2.99 [1.74-5.13],7.606573083521347e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,28076,382,1.29 [0.97-1.71],0.0787667367495437
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,23286,788,1.37 [1.12-1.67],0.0018955294635637
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27696,1049,1.39 [1.17-1.64],0.0001705551797545
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27288,196,0.91 [0.61-1.36],0.6590745831123301
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22783,1240,1.32 [1.13-1.54],0.0006096795601905
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),24313,1815,1.23 [1.08-1.40],0.0023756738285923
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27422,84,3.47 [2.21-5.44],6.45874952253875e-08
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27346,792,1.38 [1.13-1.68],0.0012892176187958
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21775,232,1.48 [1.03-2.13],0.0356611962163062
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28064,98,0.61 [0.34-1.09],0.0929375870233087
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21894,351,1.26 [0.93-1.70],0.1358243094870205
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26787,140,1.82 [1.16-2.86],0.0093616722004786
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,28205,60,1.48 [0.73-3.01],0.2760760971656821
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,27109,132,1.44 [0.89-2.32],0.1375966619702709
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Toxic colitis,26586,32,1.87 [0.73-4.78],0.1898873152775756
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22688,190,1.69 [1.14-2.51],0.0090021585025289
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,26703,149,1.34 [0.85-2.11],0.2112067696990087
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26683,129,1.35 [0.83-2.20],0.2313048361429495
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Umbilical hernia,24533,286,1.15 [0.83-1.60],0.397313367600301
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21644,101,1.54 [0.89-2.66],0.1260670258693896
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Ventral hernia,24473,226,1.76 [1.23-2.50],0.0017569322422669
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XI Diseases of the digestive system,Volvulus,21607,64,1.32 [0.65-2.67],0.4371095170755411
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,28158,163,1.49 [0.96-2.30],0.0761165534103537
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27934,77,2.74 [1.67-4.48],6.36006245328297e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26714,152,1.16 [0.73-1.83],0.5254721638846436
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27579,565,1.41 [1.12-1.78],0.0037588812727716
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27217,203,1.34 [0.91-1.98],0.14011780994364
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26738,176,2.39 [1.65-3.46],3.6914366237995126e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27948,232,1.06 [0.73-1.53],0.7753902034692634
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28116,400,1.52 [1.16-1.99],0.0025561841907946
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27765,49,3.38 [1.98-5.78],7.767594525346475e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26723,2632,1.23 [1.10-1.37],0.0001755389011205
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27751,458,0.87 [0.67-1.13],0.2908024322152875
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27618,325,0.82 [0.60-1.12],0.2109845207637312
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27815,801,1.34 [1.10-1.62],0.003827331027095
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",28202,48,0.88 [0.39-2.00],0.766424410427438
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26620,58,3.17 [1.76-5.70],0.0001238501698421
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27335,42,1.31 [0.56-3.05],0.5386098766868463
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27941,225,1.10 [0.76-1.60],0.6128767832790534
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26852,290,1.01 [0.73-1.41],0.942607383583456
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,26599,37,1.07 [0.42-2.73],0.8820684939068885
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,28130,72,1.13 [0.59-2.19],0.7088440514403728
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,27148,134,1.36 [0.85-2.20],0.2018289323245186
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28020,163,1.29 [0.83-1.99],0.2529873474261708
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27749,33,2.12 [0.86-5.25],0.1041844286025206
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,26616,54,0.60 [0.27-1.31],0.1994592011224153
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27680,1118,1.39 [1.17-1.64],0.0001083054959642
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26883,321,1.05 [0.77-1.45],0.7414428609609003
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,26602,40,1.10 [0.45-2.69],0.8403300471369128
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28132,275,1.45 [1.04-2.02],0.0269491111962556
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27779,63,2.18 [1.15-4.12],0.016449856567856
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28083,226,1.65 [1.16-2.36],0.0058333638160235
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28182,187,1.50 [1.00-2.25],0.0511074596734977
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26688,126,1.15 [0.70-1.91],0.5766833780935277
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26751,189,1.20 [0.80-1.82],0.3779781996316862
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28172,177,1.42 [0.94-2.17],0.0995154636576715
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",26694,132,2.32 [1.48-3.63],0.000249557766915
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,28181,123,1.14 [0.69-1.88],0.6218263660435299
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,24788,139,1.18 [0.73-1.89],0.497296395714592
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,26348,4760,1.18 [1.08-1.28],0.0001018729394497
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,24953,3365,1.22 [1.11-1.35],5.365279225789031e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,24746,97,1.24 [0.70-2.18],0.4591916704675982
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25321,157,1.33 [0.86-2.06],0.1991001305019853
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25329,165,2.05 [1.38-3.05],0.0003561813966173
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27980,118,1.44 [0.88-2.36],0.1489037527720466
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",25211,47,1.73 [0.79-3.78],0.172653451892468
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22355,767,1.33 [1.09-1.63],0.0052772056502233
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28154,125,1.17 [0.71-1.94],0.5347092827845668
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25464,300,1.41 [1.03-1.94],0.0332216706351472
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,24682,6384,1.15 [1.07-1.24],8.007177220110224e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26814,112,2.17 [1.34-3.53],0.0017258518989545
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,24763,114,2.01 [1.23-3.26],0.0049981550897944
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25273,624,1.03 [0.82-1.29],0.8050604082276142
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,27307,2143,1.18 [1.05-1.33],0.0066680276633364
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24879,230,1.13 [0.78-1.64],0.5249300142581121
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24933,284,1.82 [1.34-2.48],0.0001173724111684
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24802,153,0.92 [0.58-1.46],0.7237878993488631
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27695,36,0.62 [0.24-1.61],0.3227307057206942
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,22932,1344,1.22 [1.05-1.42],0.0108606823735545
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21990,402,1.46 [1.11-1.91],0.0064797924158129
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28161,394,1.48 [1.12-1.96],0.0052243921571
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21660,72,0.62 [0.31-1.22],0.1650468388072135
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21942,354,1.53 [1.13-2.06],0.0052448699600869
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24982,333,1.06 [0.78-1.45],0.6989537347705596
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22369,781,1.18 [0.97-1.44],0.1062290651808108
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,25192,28,0.87 [0.30-2.56],0.8039610154153829
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25729,565,1.32 [1.05-1.67],0.0179794544509527
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25454,290,1.26 [0.91-1.74],0.1674370097782851
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22317,729,1.15 [0.93-1.42],0.1932426471976138
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,24736,87,1.93 [1.11-3.36],0.0191120115668427
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",24712,63,0.97 [0.48-1.98],0.9425943563942144
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,26759,57,2.06 [1.06-3.99],0.0332957078685811
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27870,1168,1.49 [1.27-1.75],1.3091360042053706e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27362,660,1.56 [1.26-1.94],5.58302926069869e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28103,353,1.89 [1.43-2.48],5.677287110042138e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,23401,1813,1.31 [1.15-1.50],4.881167131432968e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,21670,82,0.90 [0.48-1.68],0.7378726607459434
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,24726,77,1.78 [0.98-3.21],0.0563065991476378
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21615,27,2.07 [0.78-5.47],0.1434365783465181
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21700,112,1.46 [0.86-2.47],0.1654661232964554
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26937,235,1.42 [0.99-2.02],0.0554148115483034
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,26948,246,1.10 [0.77-1.59],0.5948376148770893
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,28173,88,1.85 [1.06-3.25],0.0315975054387117
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26762,1598,1.17 [1.01-1.34],0.0313364944352888
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24771,122,1.88 [1.18-3.00],0.007742853582359
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21707,119,1.63 [0.99-2.68],0.0573205059890509
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25810,646,1.32 [1.06-1.64],0.0126380741278328
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23664,2076,1.22 [1.08-1.38],0.0018527574217297
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27716,57,1.60 [0.78-3.30],0.1986937993215155
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,28188,73,2.72 [1.64-4.53],0.0001118618219707
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24731,82,1.17 [0.63-2.17],0.6230195128328436
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25770,1121,1.37 [1.16-1.61],0.0001906058090013
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,24716,67,1.74 [0.91-3.34],0.0964673204996128
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22727,1139,1.34 [1.14-1.58],0.0005312875840348
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26806,104,1.25 [0.73-2.15],0.4231124839311904
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,24718,69,1.04 [0.53-2.04],0.9154353827619574
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,25285,121,1.25 [0.75-2.08],0.3841641691377484
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,25059,410,1.46 [1.12-1.91],0.0059250881823453
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27870,211,2.61 [1.89-3.62],7.886086500821216e-09
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25639,475,1.37 [1.07-1.76],0.013755767958305
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28112,333,1.88 [1.42-2.50],1.1141497907413029e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,28198,39,1.16 [0.47-2.86],0.7457352619960563
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24860,211,1.36 [0.93-1.99],0.117515004604068
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22643,609,1.47 [1.17-1.84],0.0007758916969761
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25163,514,1.22 [0.95-1.55],0.1123199834646977
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24823,174,1.14 [0.74-1.75],0.5559276198932932
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21625,37,1.83 [0.77-4.34],0.1691879317538601
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,23388,1800,1.39 [1.22-1.59],6.662369921407958e-07
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,22041,453,1.56 [1.21-2.02],0.0007108354057172
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27746,87,2.42 [1.42-4.11],0.001079348343084
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",28137,52,2.45 [1.24-4.84],0.0096525761989343
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",26577,29,1.68 [0.61-4.61],0.3116547119789004
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21663,75,2.58 [1.58-4.21],0.0001594887547478
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,25259,95,0.88 [0.49-1.58],0.6719762674181007
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21945,357,1.98 [1.50-2.62],1.8263753231062875e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24922,273,1.06 [0.76-1.50],0.7230918552737158
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25381,217,0.92 [0.63-1.35],0.6684805052660834
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,25273,109,1.69 [1.01-2.83],0.0445293397703991
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,23918,50,1.65 [0.76-3.59],0.2097914701126266
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",28201,42,1.21 [0.51-2.88],0.6673929997424779
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25263,614,1.08 [0.86-1.35],0.5155224306335658
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27747,88,3.92 [2.65-5.81],9.302132384453384e-12
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,27109,2460,1.19 [1.06-1.33],0.0023200584043196
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24759,110,1.28 [0.75-2.17],0.3636119935653753
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25527,363,1.16 [0.86-1.56],0.3219138695233728
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26799,193,1.06 [0.71-1.60],0.7653307796025071
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,25320,156,1.56 [1.01-2.40],0.0458801714677199
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,26244,1080,1.19 [1.01-1.41],0.0395139396491537
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25881,717,1.27 [1.03-1.56],0.0227264465008025
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],24692,43,1.27 [0.55-2.92],0.5714926192531985
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27807,148,2.57 [1.76-3.77],1.247496667895007e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24810,161,0.98 [0.63-1.54],0.9396209078296864
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,24707,58,1.98 [1.01-3.91],0.0479363347380728
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21627,39,1.34 [0.55-3.23],0.5200076634175128
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27639,877,2.32 [1.95-2.77],6.900187311060339e-21
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11473,78,1.81 [1.03-3.16],0.0376640188760488
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15238,76,1.05 [0.55-1.98],0.8890568414338146
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27916,331,0.99 [0.73-1.35],0.950808283190647
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27644,59,0.64 [0.30-1.34],0.238483350825518
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27467,705,3.40 [2.85-4.07],7.190750408146297e-41
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,28021,33,4.24 [2.36-7.61],1.3785481012600862e-06
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,28037,194,0.94 [0.63-1.42],0.7801583728815618
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Cystitis,25950,165,1.31 [0.85-2.02],0.2254372817829335
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Dialysis,26825,63,8.48 [5.93-12.13],1.0972081064059286e-31
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,12186,1163,1.06 [0.89-1.25],0.5262439186712499
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15368,206,1.19 [0.81-1.75],0.3788877352526992
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,11539,144,1.42 [0.91-2.21],0.1183728022156298
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11784,389,0.97 [0.74-1.29],0.8485537862456358
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11828,433,0.96 [0.73-1.26],0.7552000743003171
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23798,4379,1.19 [1.09-1.29],8.243469454916367e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,28057,69,4.86 [3.38-7.01],1.976413592278955e-17
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,11111,88,1.19 [0.66-2.17],0.5606314069557261
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,26674,229,1.23 [0.85-1.78],0.2793765513387763
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11791,768,1.14 [0.93-1.40],0.2087743827038587
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15227,243,1.32 [0.93-1.88],0.1209029604310752
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11128,105,1.17 [0.68-2.02],0.5699715329989736
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,15230,130,0.95 [0.58-1.55],0.8361628442772563
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11692,297,0.99 [0.72-1.36],0.9274768987520658
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25854,69,2.08 [1.11-3.90],0.0219107780492902
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12840,1445,0.92 [0.79-1.06],0.2402575093221524
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,11072,49,1.12 [0.50-2.49],0.7793296886987282
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11499,104,1.01 [0.59-1.75],0.962140049132318
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",28203,38,1.23 [0.50-3.01],0.6562029133818272
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",28210,48,1.75 [0.81-3.77],0.154105449267549
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,27329,1544,1.31 [1.14-1.51],0.000160543723513
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26261,476,1.00 [0.77-1.30],0.9840501662935428
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15231,69,1.46 [0.76-2.81],0.25223859288658
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28163,320,1.19 [0.87-1.62],0.2838986786669356
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11181,158,1.15 [0.73-1.80],0.5434476465749041
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11143,120,0.89 [0.53-1.50],0.670540933307825
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,11102,79,0.76 [0.40-1.44],0.3981334071237917
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,28176,54,1.09 [0.51-2.32],0.819823736861512
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26900,1115,1.45 [1.23-1.71],1.1672112653984165e-05
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15110,126,1.72 [1.07-2.76],0.0263960031955331
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11482,87,0.87 [0.48-1.59],0.6554180505044986
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11629,234,0.87 [0.61-1.26],0.4748610392954689
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11455,60,0.92 [0.45-1.91],0.8300814841140639
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11503,108,0.90 [0.52-1.54],0.6916133191163052
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26708,263,1.32 [0.93-1.86],0.1197914780574252
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27954,111,1.08 [0.63-1.84],0.7722002012289653
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11582,187,1.12 [0.75-1.67],0.5895599399830971
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11478,83,0.64 [0.34-1.18],0.1505919313264191
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11837,442,0.82 [0.62-1.07],0.1395140668299742
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11464,69,0.48 [0.24-0.95],0.0358658713377814
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11785,390,0.78 [0.59-1.04],0.0968520773280881
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,28036,48,2.01 [0.94-4.27],0.0712910733690035
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11129,106,0.84 [0.48-1.46],0.5336261282360966
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,28003,1558,2.15 [1.88-2.45],2.946559163638753e-29
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26583,138,2.30 [1.50-3.53],0.0001422592464428
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26843,81,4.37 [2.76-6.92],3.0207123217449056e-10
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27654,69,0.79 [0.40-1.56],0.4950904197432108
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25957,172,1.32 [0.86-2.02],0.2006038352520708
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27978,393,0.99 [0.75-1.32],0.9655694567182728
PDCD1LG2,Programmed cell death 1 ligand 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11498,103,0.68 [0.39-1.18],0.1718709152783978
